International Field Testing of the Psychometric Properties of an EORTC Quality of Life Module for Oral Health: the EORTC QLQ-OH15
Overview
Oncology
Authors
Affiliations
Purpose: This international EORTC validation study (phase IV) is aimed at testing the psychometric properties of a quality of life (QoL) module related to oral health problems in cancer patients.
Methods: The phase III module comprised 17 items with four hypothesized multi-item scales and three single items. In phase IV, patients with mixed cancers, in different treatment phases from 10 countries completed the EORTC QLQ-C30, the QLQ-OH module, and a debriefing interview. The hypothesized structure was tested using combinations of classical test theory and item response theory, following EORTC guidelines. Test-retest assessments and responsiveness to change analysis (RCA) were performed after 2 weeks.
Results: Five hundred seventy-two patients (median age 60.3, 54 % females) were analyzed. Completion took <10 min for 84 %, 40 % expressed satisfaction that these issues were addressed. Analyses suggested a revision of the phase III hypothesized scale structure. Two items were deleted based on a high degree of item misfit, together with negative patient feedback. The remaining 15 items formed one eight-item scale named OH-QoL score, a two-item information scale, a two-item scale regarding dentures, and three single items (sticky saliva/mouth soreness/sensitivity to food/drink). Face and convergent validity and internal consistency were confirmed. Test-retest reliability (n = 60) was demonstrated as was RCA for patients undergoing chemotherapy (n = 117; p = 0.06). The resulting QLQ-OH15 discriminated between clinically distinct patient groups, e.g., low performance status vs. higher (p < 000.1), and head-and-neck cancer versus other cancers (p < 0.03).
Conclusion: The EORTC module QLQ-OH15 is a short, well-accepted assessment tool focusing on oral problems and QoL to improve clinical management.
Trial Registration: ClinicalTrials.gov Identifier: NCT01724333.
Agrawal N, Gupta N, Siddiqui S Indian J Palliat Care. 2025; 31(1):52-59.
PMID: 40027978 PMC: 11866660. DOI: 10.25259/IJPC_242_2024.
Bulthuis M, van Gennip L, Thomas R, van Leeuwen S, Bronkhorst E, Laheij A BMC Oral Health. 2024; 24(1):1058.
PMID: 39256697 PMC: 11389434. DOI: 10.1186/s12903-024-04804-7.
Self-perceived oral health in hemato-oncological patients and the relation to quality of life.
Laheij A, Dillen L, Nur E, Raber-Durlacher J Support Care Cancer. 2024; 32(10):643.
PMID: 39243322 PMC: 11380634. DOI: 10.1007/s00520-024-08849-w.
Uhlig S, Doberschutz F, Hallmann F, Salm H, Sigle J, Pink D Support Care Cancer. 2024; 32(8):491.
PMID: 38976073 PMC: 11231016. DOI: 10.1007/s00520-024-08671-4.
Deana N, Pardo Y, Ferrer M, Espinoza-Espinoza G, Garin O, Munoz-Millan P Health Qual Life Outcomes. 2024; 22(1):5.
PMID: 38218930 PMC: 10787424. DOI: 10.1186/s12955-023-02218-7.